Tech Company Financing Transactions
Semprus BioSciences Funding Round
Semprus BioSciences secured a $8 million Series A financing round on 12/14/2008. Backers included 5AM Ventures and Pangaea Ventures.
Transaction Overview
Company Name
Announced On
12/14/2008
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
5AM Ventures (Lead Investor) (Scott Rocklage)
Pangaea Ventures (Lead Investor)
Proceeds Purpose
The proceeds of this financing will be used to advance SEMPRUS' product candidates.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
One Kendall Street Building 1400 1st Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Scott Rocklage
Chief Executive Officer
David Lucchino
Chief Technical Officer
Chris Loose
VP - Bus. Development
David McClellan
VP - Manufacturing
Douglas Weaver
VP - Product Management
Laurence Roth
Browse more venture capital transactions:
Prev: 12/12/2008: Uptake Medical venture capital transaction
Next: 12/15/2008: Discera venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs